• Aspirin at arrival for acute myocardial infarction• Beta blocker at time of arrival for acute myocardial infarction• Hemoglobin A1c control in patients with Type I or Type II diabetes mellitus• Low-density lipoprotein control in patients with Type I or Type II diabetes mellitus• High blood pressure control in patients with Type I or Type II diabetes mellitus• Angiotensin-converting enzyme inhibitor or angiotensin-receptor blocker therapy for left ventricular systolic dysfunction• Beta-blocker therapy for patients with prior myocardial infarction• Assessment of elderly patients for falls• Dialysis dose in end-stage renal disease...
To read the full article, sign in and subscribe to tci Medicare Compliance & Reimbursement.
Keep pace with evolving Medicare regulations — and onboard your team — with timely analysis of critical updates interpreted in an easy-to-follow, easy-to-apply format. Your subscription to TCI's Medicare Compliance & Reimbursement Alert will equip you to navigate code and guideline changes, CCI edits, and revisions to modifiers, payer policies, the fee schedule, OIG target areas, and more.
Current newsletters added each month
Fully searchable archives - over 4200 articles
ALL years/issues back to 2003 organized by year and issue
Codes mentioned in articles are linked to Code Information pages
Code Information pages link back to related articles
Access to this feature is available in the following products: